These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29130644)

  • 21. The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
    Munasinghe LL; Yin W; Nathani H; Toy J; Sereda P; Barrios R; Montaner JSG; Lima VD
    Soc Sci Med; 2024 Jun; 350():116920. PubMed ID: 38703468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving the UNAIDS 95-95-95 treatment target by 2025 in Ghana: a myth or a reality?
    Boakye DS; Adjorlolo S
    Glob Health Action; 2023 Dec; 16(1):2271708. PubMed ID: 37921654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards UNAIDS Fast-Track goals: targeting priority geographic areas for HIV prevention and care in Zimbabwe.
    Cuadros DF; Li J; Mukandavire Z; Musuka GN; Branscum AJ; Sartorius B; Mugurungi O; Tanser F
    AIDS; 2019 Feb; 33(2):305-314. PubMed ID: 30557161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant Improvements Are Needed in HIV Care Continuum to Meet 90-90-90 Targets in Georgia.
    Chkhartishvili N; Chokoshvili O; Dvali N; Abutidze A; Sharvadze L; Tsertsvadze T
    J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):451-454. PubMed ID: 27629869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada.
    Lima VD; Brumme ZL; Brumme C; Sereda P; Krajden M; Wong J; Guillemi SA; Henry B; Hogg RS; Barrios R; Montaner JSG;
    Curr HIV/AIDS Rep; 2020 Apr; 17(2):77-87. PubMed ID: 32124189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.
    Kripke K; Reed J; Hankins C; Smiley G; Laube C; Njeuhmeli E
    PLoS One; 2016; 11(10):e0155734. PubMed ID: 27783681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada.
    Salters KA; Parent S; Nicholson V; Wang L; Sereda P; Pakhomova TE; Kibel M; Chau W; Closson K; Parashar S; Barrios R; Montaner JSG; Hogg RS
    BMC Public Health; 2021 Apr; 21(1):680. PubMed ID: 33832472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achieving the 95 95 95 targets for all: A pathway to ending AIDS.
    Frescura L; Godfrey-Faussett P; Feizzadeh A A; El-Sadr W; Syarif O; Ghys PD;
    PLoS One; 2022; 17(8):e0272405. PubMed ID: 35925943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target.
    Marsh K; Eaton JW; Mahy M; Sabin K; Autenrieth CS; Wanyeki I; Daher J; Ghys PD
    AIDS; 2019 Dec; 33 Suppl 3(Suppl 3):S213-S226. PubMed ID: 31490781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study.
    Lima VD; Goldberg N; Lourenço L; Chau W; Hogg RS; Guillemi S; Barrios R; Montaner JS
    BMC Health Serv Res; 2015 Sep; 15():376. PubMed ID: 26369664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada.
    Eyawo O; Hull MW; Salters K; Samji H; Cescon A; Sereda P; Lima VD; Nosyk B; Whitehurst DGT; Lear SA; Montaner JSG; Hogg RS;
    BMJ Open; 2018 Jan; 8(1):e019115. PubMed ID: 29331972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings.
    Lima VD; Hull M; McVea D; Chau W; Harrigan PR; Montaner JS
    J Int AIDS Soc; 2016; 19(1):20978. PubMed ID: 27499064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.
    Enns B; Min JE; Panagiotoglou D; Montaner JSG; Nosyk B;
    BMC Health Serv Res; 2019 Sep; 19(1):626. PubMed ID: 31481056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
    Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
    J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
    Salters KA; Cescon A; Zhang W; Ogilvie G; Murray MC; Coldman A; Hamm J; Chiu CG; Montaner JS; Wiseman SM; Money D; Pick N; Hogg RS
    HIV Med; 2016 Mar; 17(3):188-95. PubMed ID: 26268461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress towards 2020 global HIV impact and treatment targets.
    Mahy MI; Sabin KM; Feizzadeh A; Wanyeki I
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25779. PubMed ID: 34546655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada.
    St-Jean M; Dong X; Tafessu H; Moore D; Honer WG; Vila-Rodriguez F; Sereda P; Hogg RS; Patterson TL; Salters K; Barrios R; Montaner JSG; Lima VD
    Int J Drug Policy; 2021 Oct; 96():103195. PubMed ID: 33773878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
    Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
    BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Antiretroviral Treatment for HIV.
    Badowski ME; Pérez SE; Biagi M; Littler JA
    Infect Dis Ther; 2016 Sep; 5(3):329-52. PubMed ID: 27539455
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.